374: Universal hepatitis C virus testing as part of prenatal care

SMFM currently recommends anti-HCV antibody testing in pregnant patients with risk factors (RFs). However, due to HCV prevalence and 95-99% cure rates using antiviral treatments, universal testing is in question. Recently (2019), there have been 2 publications on universal HCV testing using simulation models both reporting cost-effectiveness. However, through a literature search, we did not find any large prospective study evaluating actual capture rates (& cost-effectiveness) comparing testing based on RFs vs.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Poster Session II Source Type: research